Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Sepsis: Page 3
Accelerate Diagnostics prices $35M stock offering
By
LabPulse.com staff writers
Its gross proceeds from the offering, before deductions, are expected to be $35 million, said Accelerate, a Tucson, AZ-based developer and supplier of identification and antimicrobial susceptibility tests (ID/AST) for bloodstream infections including sepsis.
August 18, 2022
VolitionRx inks research deal with MD Anderson
By
LabPulse.com staff writers
Financial and other terms of the agreement were not disclosed.
August 10, 2022
Abionic nabs IVDR certification for sepsis test
By
LabPulse.com staff writers
The device detects pancreatic stone protein, an early marker for sepsis, allowing for its identification in about five minutes, Abionic said.
August 8, 2022
Video from AACC: Cytovale immune-response test for sepsis
By
Leo O'Connor
The San Francisco-based startup has submitted an application to the U.S. Food and Drug Administration (FDA) for clearance of the system and test, which aims to help emergency departments to more effectively and quickly triage patients.
July 28, 2022
Cytovale to present new data on rapid sepsis test at AACC
By
LabPulse.com staff writers
The firm noted it has already submitted an application to the U.S. Food and Drug Administration for clearance of the system and test, which aims to help emergency departments rapidly and more effectively triage patients.
July 24, 2022
Nanomix, Biotron ink distribution deal
By
LabPulse.com staff writers
Under the terms of the deal, Biotron also will market the Nanomix S1 panel cartridge, which diagnoses infections, including sepsis, and future new product cartridges for the eLab system.
July 20, 2022
Bluejay Diagnostics completes clinical studies for sepsis triage
By
LabPulse.com staff writers
The Acton, MA-based firm said it will present the study results at the 2022 AACC Annual Scientific Meeting being held from July 26 to July 28 in Chicago.
July 5, 2022
Nanomix launches trial of eLab analyzer and panel
By
LabPulse.com staff writers
The company's eLab system is a mobile, handheld immunoassay and chemistry diagnostic system designed for rapid point-of-care testing, while the S1 Panel Cartridge was developed to aid in diagnosing critical infections, including sepsis. The panel provides quantitative test results for procalcitonin (PCT), C-reactive protein (CRP), and lactate (LAC) from a single venous whole blood or plasma sample type.
June 22, 2022
Pathogenomix gets FDA designation for Patho-Seq assay
By
LabPulse.com staff writers
Patho-Seq was designed for the rapid detection and identification of hundreds of clinically relevant bacteria for a broad list of clinical conditions and sample types, including sepsis from whole blood samples and bacterial meningitis from cerebrospinal fluid, Pathogenomix said.
January 19, 2022
Immunexpress sepsis test gets FDA 510(k) clearance
By
LabPulse.com staff writers
SeptiCyte Rapid uses reverse transcription polymerase chain reaction to quantify directly from blood the relative expression of genes involved in a patient's immune response, the company said.
November 29, 2021
Prenosis gets $4.3M to develop sepsis test for U.S. military
By
LabPulse.com staff writers
Prenosis has developed an emergency point-of-care (ePOC) system, which builds upon its Immunix platform that uses machine-learning algorithms to identify sepsis as early as possible in hospitals. Now, the platform will be adapted for use on service members on the frontlines by replacing the standard large clinical lab analyzers with a mobile system.
November 16, 2021
Inflammatix wins $1.7M NIH grant
By
LabPulse.com staff writers
Using host immune mRNA signatures, the company has identified three sepsis subtypes ("endotypes"). The NIH award will allow Inflammatix to further investigate each endotype's signature and to develop a rapid, 30-minute test to identify them, it said.
November 14, 2021
Previous Page
Page 3 of 6
Next Page